ClinicalTrials.Veeva

Menu

Artificial Intelligence (AI) - Assisted Visual Impairment Screening Model: Community-based Implementation and Evaluation of Performance, Feasibility and Costs.

S

Singapore Eye Research Institute

Status

Enrolling

Conditions

Visual Impairment

Treatments

Device: AI

Study type

Interventional

Funder types

Other

Identifiers

NCT06877988
2024/2297

Details and patient eligibility

About

The goal of this observational study is to evaluate the performance, operational efficiency, acceptability, feasibility, and cost-effectiveness of an AI-assisted screening model for visual impairment in a community setting. The main questions it aims to answer are:

  • Can the AI-assisted screening model improve screening and referral accuracy compared to the current traditional screening approach?
  • Does the AI-assisted model enhance operational efficiency and reduce healthcare costs in a community setting?

Researchers will compare the AI-assisted model with the current traditional screening approach to assess its impact on screening accuracy, operational efficiency, and cost-effectiveness.

Participants will:

  • Undergo vision screening using either the AI-assisted model or the traditional model.
  • Provide feedback on the acceptability of the screening approach.
  • Contribute to evaluating the feasibility and costs associated with each screening method.

Enrollment

400 estimated patients

Sex

All

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals aged 50 years old and above.

Exclusion criteria

  • Individuals aged below 50 years old.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

400 participants in 2 patient groups

AI-assisted
Experimental group
Description:
Participants will undergo visual impairment screening using AVIRI model (AI for Disease-related Visual Impairment Screening Using Retinal Imaging). This intervention involves automated fundus image analysis through artificial intelligence to screen and identify individuals with high probability of visual impairment.
Treatment:
Device: AI
Traditional
No Intervention group
Description:
Participants will receive visual impairment screening using the traditional screening model, which involves optometrists performing initial assessments, followed by referral decisions based on manual fundus image evaluation.

Trial contacts and locations

1

Loading...

Central trial contact

Kaeley Koh; Clarine Ho

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems